These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. Buxton DB; Nienaber CA; Luxen A; Ratib O; Hansen H; Phelps ME; Schelbert HR Circulation; 1989 Jan; 79(1):134-42. PubMed ID: 2783396 [TBL] [Abstract][Full Text] [Related]
28. Effect of nicotinic acid on exogenous myocardial glucose utilization. Stone CK; Holden JE; Stanley W; Perlman SB J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458 [TBL] [Abstract][Full Text] [Related]
29. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795 [TBL] [Abstract][Full Text] [Related]
30. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study. Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634 [TBL] [Abstract][Full Text] [Related]
31. [Glucose metabolism in ischemic myocardium: quantitative imaging using positron emission tomography]. Takahashi A; Ono Y; Sudo M; Araki K; Shishido F; Uemura K; Kadowaki K; Kumagai T J Cardiogr; 1986 Jun; 16(2):291-9. PubMed ID: 3495606 [TBL] [Abstract][Full Text] [Related]
33. Use and limitations of metabolic tracers labeled with positron-emitting radionuclides in the identification of viable myocardium. Bergmann SR J Nucl Med; 1994 Apr; 35(4 Suppl):15S-22S. PubMed ID: 8151408 [TBL] [Abstract][Full Text] [Related]
34. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Bax JJ; Veening MA; Visser FC; van Lingen A; Heine RJ; Cornel JH; Visser CA Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874 [TBL] [Abstract][Full Text] [Related]
35. [Assessment of myocardial energy metabolism with PET]. Kinoshita S; Serizawa T Nihon Rinsho; 1997 Mar; 55 Suppl 1():644-7. PubMed ID: 9097693 [No Abstract] [Full Text] [Related]
36. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. Gambhir SS; Schwaiger M; Huang SC; Krivokapich J; Schelbert HR; Nienaber CA; Phelps ME J Nucl Med; 1989 Mar; 30(3):359-66. PubMed ID: 2786939 [TBL] [Abstract][Full Text] [Related]
37. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition. Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154 [TBL] [Abstract][Full Text] [Related]